

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chemosensory behavior (GO:0007635) | 7.99431995 |
| 2 | male sex determination (GO:0030238) | 7.12674957 |
| 3 | glucosamine-containing compound catabolic process (GO:1901072) | 6.86777039 |
| 4 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.87093266 |
| 5 | protein K6-linked ubiquitination (GO:0085020) | 5.80059715 |
| 6 | carnitine shuttle (GO:0006853) | 5.68368998 |
| 7 | autophagic vacuole fusion (GO:0000046) | 5.52606543 |
| 8 | adenosine metabolic process (GO:0046085) | 5.48540834 |
| 9 | sleep (GO:0030431) | 5.01622193 |
| 10 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.92281542 |
| 11 | carnitine transport (GO:0015879) | 4.87502339 |
| 12 | amino-acid betaine transport (GO:0015838) | 4.87502339 |
| 13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.85614204 |
| 14 | fatty acid transmembrane transport (GO:1902001) | 4.85328198 |
| 15 | carnitine transmembrane transport (GO:1902603) | 4.81209188 |
| 16 | intracellular lipid transport (GO:0032365) | 4.78442145 |
| 17 | positive regulation of glycolytic process (GO:0045821) | 4.68064630 |
| 18 | coenzyme A biosynthetic process (GO:0015937) | 4.62197246 |
| 19 | response to lipoprotein particle (GO:0055094) | 4.52651697 |
| 20 | response to UV-C (GO:0010225) | 4.32331866 |
| 21 | amino sugar catabolic process (GO:0046348) | 4.20459402 |
| 22 | coenzyme A metabolic process (GO:0015936) | 4.14026797 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.09858913 |
| 24 | organelle membrane fusion (GO:0090174) | 4.09811965 |
| 25 | nitric oxide mediated signal transduction (GO:0007263) | 3.98169952 |
| 26 | positive regulation of cholesterol efflux (GO:0010875) | 3.86051021 |
| 27 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.85234458 |
| 28 | positive regulation of sterol transport (GO:0032373) | 3.83536663 |
| 29 | positive regulation of cholesterol transport (GO:0032376) | 3.83536663 |
| 30 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.81757323 |
| 31 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.81453729 |
| 32 | RNA destabilization (GO:0050779) | 3.80799303 |
| 33 | nucleotide transmembrane transport (GO:1901679) | 3.80059137 |
| 34 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.68624523 |
| 35 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.65244581 |
| 36 | response to acidic pH (GO:0010447) | 3.65146366 |
| 37 | sex determination (GO:0007530) | 3.49193813 |
| 38 | positive regulation of glycogen metabolic process (GO:0070875) | 3.48590247 |
| 39 | centrosome duplication (GO:0051298) | 3.44386473 |
| 40 | fatty acid homeostasis (GO:0055089) | 3.41754262 |
| 41 | quaternary ammonium group transport (GO:0015697) | 3.39631671 |
| 42 | arginine catabolic process (GO:0006527) | 3.33186916 |
| 43 | genitalia morphogenesis (GO:0035112) | 3.27545910 |
| 44 | oocyte maturation (GO:0001556) | 3.27445735 |
| 45 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.25755587 |
| 46 | cellular response to leptin stimulus (GO:0044320) | 3.24804238 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.24086216 |
| 48 | negative regulation of lipid storage (GO:0010888) | 3.20961577 |
| 49 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.14163824 |
| 50 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.14009866 |
| 51 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.14009866 |
| 52 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.14009866 |
| 53 | positive regulation of macroautophagy (GO:0016239) | 3.13674498 |
| 54 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.11372342 |
| 55 | uterus development (GO:0060065) | 3.10382466 |
| 56 | valine metabolic process (GO:0006573) | 3.07674230 |
| 57 | cellular protein complex localization (GO:0034629) | 3.07590620 |
| 58 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.06304314 |
| 59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.06304314 |
| 60 | retinal rod cell development (GO:0046548) | 3.04678265 |
| 61 | regulation of immunoglobulin secretion (GO:0051023) | 3.01290201 |
| 62 | mannosylation (GO:0097502) | 3.00150173 |
| 63 | regulation of establishment of cell polarity (GO:2000114) | 2.98784069 |
| 64 | detection of light stimulus involved in visual perception (GO:0050908) | 2.98718170 |
| 65 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.98718170 |
| 66 | negative regulation of protein oligomerization (GO:0032460) | 2.97966275 |
| 67 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.97665438 |
| 68 | cAMP catabolic process (GO:0006198) | 2.95984187 |
| 69 | regulation of memory T cell differentiation (GO:0043380) | 2.94239359 |
| 70 | cullin deneddylation (GO:0010388) | 2.91927936 |
| 71 | negative regulation of gluconeogenesis (GO:0045721) | 2.90110012 |
| 72 | hyaluronan catabolic process (GO:0030214) | 2.88845865 |
| 73 | negative regulation of heart growth (GO:0061117) | 2.85035143 |
| 74 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.85035143 |
| 75 | male meiosis I (GO:0007141) | 2.84708279 |
| 76 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.84226350 |
| 77 | regulation of protein glycosylation (GO:0060049) | 2.83888286 |
| 78 | regulation of hexokinase activity (GO:1903299) | 2.83101588 |
| 79 | regulation of glucokinase activity (GO:0033131) | 2.83101588 |
| 80 | positive regulation of autophagy (GO:0010508) | 2.82217777 |
| 81 | histone H2A acetylation (GO:0043968) | 2.79893016 |
| 82 | zinc ion homeostasis (GO:0055069) | 2.78629757 |
| 83 | omega-hydroxylase P450 pathway (GO:0097267) | 2.77744300 |
| 84 | inner cell mass cell proliferation (GO:0001833) | 2.77238941 |
| 85 | cyclic nucleotide catabolic process (GO:0009214) | 2.75185848 |
| 86 | positive regulation of respiratory burst (GO:0060267) | 2.74794672 |
| 87 | regulation of cholesterol efflux (GO:0010874) | 2.74591473 |
| 88 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.74043029 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 2.73806222 |
| 90 | arginine metabolic process (GO:0006525) | 2.73259694 |
| 91 | regulation of glycogen metabolic process (GO:0070873) | 2.72123194 |
| 92 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.72054634 |
| 93 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.71391413 |
| 94 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.69372176 |
| 95 | positive regulation of glucose metabolic process (GO:0010907) | 2.68806859 |
| 96 | maintenance of protein location in nucleus (GO:0051457) | 2.67152707 |
| 97 | protein deneddylation (GO:0000338) | 2.67136086 |
| 98 | negative regulation of cell cycle arrest (GO:0071157) | 2.66691721 |
| 99 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.64232414 |
| 100 | early endosome to late endosome transport (GO:0045022) | 2.64170624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.12031204 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.08308143 |
| 3 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.05930982 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 4.03360899 |
| 5 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.82072861 |
| 6 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.65202327 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60632181 |
| 8 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.46143496 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.32238955 |
| 10 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.20323752 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.11957570 |
| 12 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.11615158 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 1.98305367 |
| 14 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.96937896 |
| 15 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.91074895 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90901563 |
| 17 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88356199 |
| 18 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.85550084 |
| 19 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.85550084 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81805905 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.80755664 |
| 22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.69796572 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68541471 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.67194704 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66627545 |
| 26 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66486888 |
| 27 | AR_20517297_ChIP-Seq_VCAP_Human | 1.60308790 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53152404 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51859461 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.49885588 |
| 31 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.48586812 |
| 32 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48586812 |
| 33 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.45175246 |
| 34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.44137379 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43021120 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42444107 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40935895 |
| 38 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37227052 |
| 39 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.36905770 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34358013 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32602292 |
| 42 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.32538137 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26330042 |
| 44 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26096204 |
| 45 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25927168 |
| 46 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25337482 |
| 47 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24816075 |
| 48 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24422989 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.22860339 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22579650 |
| 51 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.22578524 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20913894 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19079634 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18679323 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18575066 |
| 56 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18129229 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16645106 |
| 58 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16645106 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16308092 |
| 60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15650795 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15650782 |
| 62 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15410553 |
| 63 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.12148149 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11303882 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11005038 |
| 66 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10523955 |
| 67 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.09611739 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09138056 |
| 69 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08930209 |
| 70 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08661041 |
| 71 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.07891827 |
| 72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05488878 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04597305 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04234038 |
| 75 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02919132 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02790600 |
| 77 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02287184 |
| 78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.02019094 |
| 79 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01787151 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01224010 |
| 81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00943498 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00943498 |
| 83 | GATA3_26560356_Chip-Seq_TH1_Human | 1.00417491 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99637262 |
| 85 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99308900 |
| 86 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.96642035 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 0.96291785 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94783128 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94744739 |
| 90 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94617158 |
| 91 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.94256241 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94068284 |
| 93 | AR_19668381_ChIP-Seq_PC3_Human | 0.93104823 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91557838 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90837459 |
| 96 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90295132 |
| 97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89856914 |
| 98 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.89674015 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89645877 |
| 100 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.87860560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 4.98782951 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.89699206 |
| 3 | MP0003195_calcinosis | 3.97962304 |
| 4 | MP0002254_reproductive_system_inflammat | 3.80178288 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.58175395 |
| 6 | MP0002653_abnormal_ependyma_morphology | 3.19216862 |
| 7 | MP0003283_abnormal_digestive_organ | 2.88383707 |
| 8 | MP0002876_abnormal_thyroid_physiology | 2.82409699 |
| 9 | MP0005310_abnormal_salivary_gland | 2.81043701 |
| 10 | MP0009840_abnormal_foam_cell | 2.79233428 |
| 11 | MP0004270_analgesia | 2.74667479 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.73546906 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.59155322 |
| 14 | MP0005647_abnormal_sex_gland | 2.58726007 |
| 15 | MP0002163_abnormal_gland_morphology | 2.49239706 |
| 16 | MP0010307_abnormal_tumor_latency | 2.34284785 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.02809079 |
| 18 | MP0001346_abnormal_lacrimal_gland | 1.96232507 |
| 19 | MP0002090_abnormal_vision | 1.89655182 |
| 20 | MP0001851_eye_inflammation | 1.88753587 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.84688217 |
| 22 | MP0001529_abnormal_vocalization | 1.80838683 |
| 23 | MP0009697_abnormal_copulation | 1.80123163 |
| 24 | MP0000427_abnormal_hair_cycle | 1.76650060 |
| 25 | MP0004510_myositis | 1.74548131 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.71631864 |
| 27 | MP0002295_abnormal_pulmonary_circulatio | 1.65183217 |
| 28 | MP0001764_abnormal_homeostasis | 1.62193522 |
| 29 | MP0003787_abnormal_imprinting | 1.47466891 |
| 30 | MP0005671_abnormal_response_to | 1.45359020 |
| 31 | MP0003724_increased_susceptibility_to | 1.45202127 |
| 32 | MP0005379_endocrine/exocrine_gland_phen | 1.45200739 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.42151914 |
| 34 | MP0010329_abnormal_lipoprotein_level | 1.40854500 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.40178090 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.28216084 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.21387611 |
| 38 | MP0004885_abnormal_endolymph | 1.14864891 |
| 39 | MP0002168_other_aberrant_phenotype | 1.09692428 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.09206614 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.09040518 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.08028945 |
| 43 | MP0003567_abnormal_fetal_cardiomyocyte | 1.07990052 |
| 44 | MP0002009_preneoplasia | 1.05481443 |
| 45 | MP0002405_respiratory_system_inflammati | 1.04374298 |
| 46 | MP0003646_muscle_fatigue | 1.03540613 |
| 47 | MP0002132_abnormal_respiratory_system | 1.03527066 |
| 48 | MP0002928_abnormal_bile_duct | 1.03317502 |
| 49 | MP0009703_decreased_birth_body | 1.03230660 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 0.99518940 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 0.98332289 |
| 52 | MP0001944_abnormal_pancreas_morphology | 0.96456595 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 0.93756273 |
| 54 | MP0003075_altered_response_to | 0.92049590 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 0.91921114 |
| 56 | MP0010678_abnormal_skin_adnexa | 0.90040769 |
| 57 | MP0002102_abnormal_ear_morphology | 0.90023438 |
| 58 | MP0006082_CNS_inflammation | 0.87740558 |
| 59 | MP0001270_distended_abdomen | 0.85641842 |
| 60 | MP0000383_abnormal_hair_follicle | 0.84403319 |
| 61 | MP0000647_abnormal_sebaceous_gland | 0.83433335 |
| 62 | MP0003252_abnormal_bile_duct | 0.79876025 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.79228181 |
| 64 | MP0009643_abnormal_urine_homeostasis | 0.78710912 |
| 65 | MP0001756_abnormal_urination | 0.78704161 |
| 66 | MP0004924_abnormal_behavior | 0.78007203 |
| 67 | MP0005386_behavior/neurological_phenoty | 0.78007203 |
| 68 | MP0003866_abnormal_defecation | 0.77256580 |
| 69 | MP0000613_abnormal_salivary_gland | 0.76661281 |
| 70 | MP0008872_abnormal_physiological_respon | 0.75968176 |
| 71 | MP0001216_abnormal_epidermal_layer | 0.75209548 |
| 72 | MP0009672_abnormal_birth_weight | 0.74281116 |
| 73 | MP0001191_abnormal_skin_condition | 0.74151976 |
| 74 | MP0001348_abnormal_lacrimal_gland | 0.73667910 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.72793368 |
| 76 | MP0000639_abnormal_adrenal_gland | 0.72516657 |
| 77 | MP0009046_muscle_twitch | 0.72023420 |
| 78 | MP0005385_cardiovascular_system_phenoty | 0.71874466 |
| 79 | MP0001544_abnormal_cardiovascular_syste | 0.71874466 |
| 80 | MP0002118_abnormal_lipid_homeostasis | 0.69637685 |
| 81 | MP0003959_abnormal_lean_body | 0.69061298 |
| 82 | MP0003303_peritoneal_inflammation | 0.68993544 |
| 83 | MP0008007_abnormal_cellular_replicative | 0.67918868 |
| 84 | MP0005253_abnormal_eye_physiology | 0.66406298 |
| 85 | MP0002557_abnormal_social/conspecific_i | 0.66071662 |
| 86 | MP0001533_abnormal_skeleton_physiology | 0.63873004 |
| 87 | MP0002723_abnormal_immune_serum | 0.63492285 |
| 88 | MP0008789_abnormal_olfactory_epithelium | 0.62803661 |
| 89 | MP0002419_abnormal_innate_immunity | 0.59157787 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.59044841 |
| 91 | MP0002971_abnormal_brown_adipose | 0.57946778 |
| 92 | MP0008058_abnormal_DNA_repair | 0.57166271 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.56779763 |
| 94 | MP0010094_abnormal_chromosome_stability | 0.56187810 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.56185792 |
| 96 | MP0001819_abnormal_immune_cell | 0.54116101 |
| 97 | MP0002452_abnormal_antigen_presenting | 0.54043396 |
| 98 | MP0001984_abnormal_olfaction | 0.53816895 |
| 99 | MP0005166_decreased_susceptibility_to | 0.53337783 |
| 100 | MP0005025_abnormal_response_to | 0.52917176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 6.68452690 |
| 2 | Abnormality of the prostate (HP:0008775) | 5.06916406 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.59635436 |
| 4 | Nuclear cataract (HP:0100018) | 4.52578341 |
| 5 | Beaking of vertebral bodies (HP:0004568) | 4.21493179 |
| 6 | Retinal atrophy (HP:0001105) | 4.14711020 |
| 7 | Hypoplasia of the thymus (HP:0000778) | 4.02285337 |
| 8 | Chromsome breakage (HP:0040012) | 3.75254905 |
| 9 | Severe visual impairment (HP:0001141) | 3.50388630 |
| 10 | Renal cortical cysts (HP:0000803) | 3.31765553 |
| 11 | Anhidrosis (HP:0000970) | 3.22869966 |
| 12 | Abnormality of male internal genitalia (HP:0000022) | 3.22590159 |
| 13 | Abnormality of macular pigmentation (HP:0008002) | 3.21291326 |
| 14 | Ketoacidosis (HP:0001993) | 3.18212516 |
| 15 | Hypochromic microcytic anemia (HP:0004840) | 3.14938569 |
| 16 | J-shaped sella turcica (HP:0002680) | 3.14536521 |
| 17 | Hypoglycemic seizures (HP:0002173) | 3.13002439 |
| 18 | Follicular hyperkeratosis (HP:0007502) | 2.96609442 |
| 19 | Spinal cord lesions (HP:0100561) | 2.91547520 |
| 20 | Syringomyelia (HP:0003396) | 2.91547520 |
| 21 | Absent frontal sinuses (HP:0002688) | 2.86464269 |
| 22 | Poor head control (HP:0002421) | 2.84819706 |
| 23 | Alopecia of scalp (HP:0002293) | 2.84480304 |
| 24 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.84423542 |
| 25 | Increased density of long bones (HP:0006392) | 2.78896932 |
| 26 | Recurrent corneal erosions (HP:0000495) | 2.76602223 |
| 27 | Nonimmune hydrops fetalis (HP:0001790) | 2.76370772 |
| 28 | Increased circulating renin level (HP:0000848) | 2.76322012 |
| 29 | Optic neuritis (HP:0100653) | 2.74036946 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 2.74036946 |
| 31 | Calf muscle hypertrophy (HP:0008981) | 2.72330204 |
| 32 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.69971008 |
| 33 | Abnormal cartilage morphology (HP:0002763) | 2.67325065 |
| 34 | Large for gestational age (HP:0001520) | 2.67043717 |
| 35 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.66940304 |
| 36 | Unilateral renal agenesis (HP:0000122) | 2.60527432 |
| 37 | Hypoglycemic coma (HP:0001325) | 2.58826706 |
| 38 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.57413441 |
| 39 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.57413441 |
| 40 | Vascular calcification (HP:0004934) | 2.57284069 |
| 41 | Orchitis (HP:0100796) | 2.56609312 |
| 42 | Arterial thrombosis (HP:0004420) | 2.55314487 |
| 43 | Sex reversal (HP:0012245) | 2.53360094 |
| 44 | Abnormal sex determination (HP:0012244) | 2.53360094 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52171443 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52171443 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52171443 |
| 48 | Hypoplasia of the odontoid process (HP:0003311) | 2.52155407 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.49247551 |
| 50 | Zonular cataract (HP:0010920) | 2.46879283 |
| 51 | Agitation (HP:0000713) | 2.46699643 |
| 52 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.46573835 |
| 53 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.46573835 |
| 54 | Type I transferrin isoform profile (HP:0003642) | 2.45112148 |
| 55 | Poor suck (HP:0002033) | 2.44890324 |
| 56 | Acute lymphatic leukemia (HP:0006721) | 2.42634467 |
| 57 | Erythroderma (HP:0001019) | 2.40953224 |
| 58 | Thyroiditis (HP:0100646) | 2.39998721 |
| 59 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.39007030 |
| 60 | Abnormality of the frontal sinuses (HP:0002687) | 2.37571897 |
| 61 | Hyperglycemia (HP:0003074) | 2.33137203 |
| 62 | Rib fusion (HP:0000902) | 2.29325117 |
| 63 | Parakeratosis (HP:0001036) | 2.28383401 |
| 64 | Prominent metopic ridge (HP:0005487) | 2.26637705 |
| 65 | Progressive microcephaly (HP:0000253) | 2.24663653 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.20792497 |
| 67 | Pendular nystagmus (HP:0012043) | 2.20611430 |
| 68 | Hematochezia (HP:0002573) | 2.18995285 |
| 69 | Polydipsia (HP:0001959) | 2.17676510 |
| 70 | Abnormal drinking behavior (HP:0030082) | 2.17676510 |
| 71 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.16926603 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16161767 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.13620859 |
| 74 | Shoulder girdle muscle weakness (HP:0003547) | 2.13445754 |
| 75 | Akinesia (HP:0002304) | 2.13104172 |
| 76 | Pelvic girdle muscle weakness (HP:0003749) | 2.12181785 |
| 77 | Abnormality of dental color (HP:0011073) | 2.12070205 |
| 78 | Abnormality of the lumbar spine (HP:0100712) | 2.11075429 |
| 79 | Severe combined immunodeficiency (HP:0004430) | 2.09850098 |
| 80 | Dysostosis multiplex (HP:0000943) | 2.09722940 |
| 81 | Keratitis (HP:0000491) | 2.06690159 |
| 82 | Hypsarrhythmia (HP:0002521) | 2.05300721 |
| 83 | Lipid accumulation in hepatocytes (HP:0006561) | 2.04871349 |
| 84 | Irregular epiphyses (HP:0010582) | 2.04371296 |
| 85 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02348051 |
| 86 | Prolonged partial thromboplastin time (HP:0003645) | 2.02300911 |
| 87 | Polyneuropathy (HP:0001271) | 2.01941278 |
| 88 | Shawl scrotum (HP:0000049) | 1.99707370 |
| 89 | Congenital primary aphakia (HP:0007707) | 1.99653566 |
| 90 | Abnormality of the metopic suture (HP:0005556) | 1.98136786 |
| 91 | Abnormality of the odontoid process (HP:0003310) | 1.97187156 |
| 92 | Myositis (HP:0100614) | 1.97183667 |
| 93 | Gait imbalance (HP:0002141) | 1.92332870 |
| 94 | Abnormal protein glycosylation (HP:0012346) | 1.91891750 |
| 95 | Abnormal glycosylation (HP:0012345) | 1.91891750 |
| 96 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.91891750 |
| 97 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.91891750 |
| 98 | Epileptiform EEG discharges (HP:0011182) | 1.91875154 |
| 99 | Abnormality of the renal cortex (HP:0011035) | 1.91515762 |
| 100 | Metatarsus adductus (HP:0001840) | 1.89179210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.65058838 |
| 2 | FRK | 3.71382796 |
| 3 | WEE1 | 3.69433490 |
| 4 | MAP3K4 | 3.49695542 |
| 5 | STK16 | 3.44578942 |
| 6 | MAP3K14 | 3.43482572 |
| 7 | TXK | 3.01107228 |
| 8 | FES | 2.91419747 |
| 9 | MAP3K13 | 2.65468975 |
| 10 | PASK | 2.48470215 |
| 11 | MATK | 2.37948490 |
| 12 | MAP3K7 | 2.19918177 |
| 13 | MAP2K2 | 2.11377236 |
| 14 | MST4 | 2.00281369 |
| 15 | SCYL2 | 1.81662665 |
| 16 | WNK3 | 1.75339282 |
| 17 | MAPK13 | 1.74556065 |
| 18 | ADRBK2 | 1.64861138 |
| 19 | EIF2AK2 | 1.59616094 |
| 20 | CASK | 1.59611769 |
| 21 | STK3 | 1.59318945 |
| 22 | MELK | 1.59033778 |
| 23 | MAP4K2 | 1.57492050 |
| 24 | PAK3 | 1.41806307 |
| 25 | GRK6 | 1.37855670 |
| 26 | CDK12 | 1.30109598 |
| 27 | PLK2 | 1.28006801 |
| 28 | PAK2 | 1.26094153 |
| 29 | BCKDK | 1.23959854 |
| 30 | TAOK3 | 1.20408096 |
| 31 | TRPM7 | 1.16227853 |
| 32 | PKN1 | 1.13393754 |
| 33 | CDK4 | 1.11710896 |
| 34 | TLK1 | 1.08292482 |
| 35 | CSNK1G1 | 1.06782670 |
| 36 | FGFR2 | 1.03727833 |
| 37 | IKBKB | 0.98305400 |
| 38 | STK38L | 0.93050274 |
| 39 | MAPKAPK3 | 0.90579627 |
| 40 | MYLK | 0.88549099 |
| 41 | NLK | 0.85606717 |
| 42 | ARAF | 0.82527851 |
| 43 | CHUK | 0.81967659 |
| 44 | ERBB2 | 0.78682331 |
| 45 | NEK9 | 0.78372882 |
| 46 | IKBKE | 0.77253285 |
| 47 | CSNK1A1L | 0.77038555 |
| 48 | ROCK1 | 0.76489394 |
| 49 | PIM2 | 0.76053197 |
| 50 | CAMK1D | 0.74959450 |
| 51 | BCR | 0.74036135 |
| 52 | KIT | 0.73054410 |
| 53 | PRKCQ | 0.69671776 |
| 54 | TAOK1 | 0.65495270 |
| 55 | MAPK3 | 0.60568646 |
| 56 | PRKAA2 | 0.58600818 |
| 57 | TNIK | 0.57998033 |
| 58 | CAMKK2 | 0.56783648 |
| 59 | GRK1 | 0.56716297 |
| 60 | CDK7 | 0.54631899 |
| 61 | OXSR1 | 0.53925092 |
| 62 | CSNK1G3 | 0.53668948 |
| 63 | HCK | 0.53480761 |
| 64 | DAPK2 | 0.53114791 |
| 65 | BRSK2 | 0.46105885 |
| 66 | ERN1 | 0.42482828 |
| 67 | STK39 | 0.41419482 |
| 68 | IGF1R | 0.40723205 |
| 69 | TBK1 | 0.40449928 |
| 70 | INSRR | 0.40323228 |
| 71 | NUAK1 | 0.39796593 |
| 72 | DMPK | 0.39625055 |
| 73 | SGK2 | 0.39082197 |
| 74 | ADRBK1 | 0.39064583 |
| 75 | PRKCZ | 0.38911935 |
| 76 | PRKD1 | 0.38822645 |
| 77 | ERBB3 | 0.38524844 |
| 78 | DAPK1 | 0.38376447 |
| 79 | ABL1 | 0.38179180 |
| 80 | LYN | 0.37985364 |
| 81 | PRKCI | 0.35983549 |
| 82 | STK24 | 0.35788342 |
| 83 | PINK1 | 0.35170823 |
| 84 | ZAK | 0.34109018 |
| 85 | RPS6KA6 | 0.34043260 |
| 86 | NTRK1 | 0.33917309 |
| 87 | PRKCE | 0.32814736 |
| 88 | CSNK1D | 0.32622373 |
| 89 | SRPK1 | 0.32140213 |
| 90 | GRK5 | 0.29968261 |
| 91 | PLK3 | 0.29206610 |
| 92 | FER | 0.29133293 |
| 93 | DDR2 | 0.29132388 |
| 94 | CDK6 | 0.28809604 |
| 95 | CDK3 | 0.28740354 |
| 96 | PRKACA | 0.28610513 |
| 97 | MAPK1 | 0.27202108 |
| 98 | CSK | 0.26636019 |
| 99 | MAPK4 | 0.26337711 |
| 100 | PHKG2 | 0.26254093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 5.19648661 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.05765481 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.47905007 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.55181140 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.44208940 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.11176948 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02301283 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84069220 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80417253 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78450528 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.73248725 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.72104131 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69308565 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68498444 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64506910 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.63716078 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.61624424 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.54925566 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.45387463 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.44501166 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.44022652 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43957239 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42490867 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.40296898 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37516404 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.33819588 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.31723606 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.31613484 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.31369390 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28837955 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27912812 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.25685647 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.24296788 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21337536 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19248356 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14468504 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.13389349 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08264148 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.06670534 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02188699 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96788060 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95588476 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95004310 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94778568 |
| 45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91386921 |
| 46 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.89575568 |
| 47 | Malaria_Homo sapiens_hsa05144 | 0.89180327 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.83175242 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79360180 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79342896 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77923172 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.77542307 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77095782 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76520552 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75853964 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.75118900 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74606578 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70633123 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67798238 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67729422 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67208798 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66703259 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63386487 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61969259 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61949125 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59285829 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57433745 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57268587 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55634337 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52893106 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49263346 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48041456 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47945505 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47505671 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45529373 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43869638 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43479579 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.43250962 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43049391 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38596485 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37779111 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37046838 |
| 83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37009480 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33882424 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32987299 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.31099274 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30446125 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.30177866 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.28265763 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28131177 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27193336 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26591650 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26513425 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.26098357 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24233984 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.23804199 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.22957592 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22505673 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.22433656 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.19139767 |

